Clinical tolerance 2008.
In 2008, three publications highlighted the transition of tolerance from experimental to experiential. These included the first study to both anticipate and reproducibly deliver human leukocyte antigen-disparate allograft survival without continuous immunosuppressive drug administration. The other two highlighted unique episodes of clinical tolerance. The results from these studies are summarized and discussed.
Department of Surgery, Emory University, Atlanta, GA 30322, USA. adkirk@emory.edu
Allan D
AD
Kirk
D000917:Antibody Formation; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007108:Immune Tolerance; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018183:Transplantation Chimera; D014181:Transplantation Immunology; D023001:Transplantation Tolerance
D007166:Immunosuppressive Agents